Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-01 Crombez Eric EVP and Chief Medical Officer Grant or award +4,658 30,512
2023-05-01 Crombez Eric EVP and Chief Medical Officer Grant or award · Stock Option (Right to Buy) +8,362 8,362
2023-04-16 Huizenga Theodore Alan SVP, Chief Accounting Officer Shares withheld for taxes −14 $38.20 $535 27,701
2023-04-16 Huizenga Theodore Alan SVP, Chief Accounting Officer Returned to the company −181 $38.20 $7K 27,520
2023-03-01 Bedrosian Camille L EVP and Chief Medical Officer Grant or award +2,663 50,601
2023-03-01 Bedrosian Camille L EVP and Chief Medical Officer Sale −3,881 $45.25 $176K 46,720
2023-03-01 Parschauer Karah Herdman EVP and Chief Legal Officer Grant or award +2,663 37,101
2023-03-01 Parschauer Karah Herdman EVP and Chief Legal Officer Grant or award +22,000 59,101
2023-03-01 Parschauer Karah Herdman EVP and Chief Legal Officer Sale −3,161 $45.25 $143K 56,139
2023-03-01 Parschauer Karah Herdman EVP and Chief Legal Officer Grant or award · Stock Option (Right to Buy) +39,400 39,400
2023-03-01 Kassberg Thomas Richard CBO & EVP Grant or award +2,663 230,222
2023-03-01 Kassberg Thomas Richard CBO & EVP Grant or award +22,000 252,222
2023-03-01 Kassberg Thomas Richard CBO & EVP Sale −1,968 $45.27 $89K 250,254
2023-03-01 Kassberg Thomas Richard CBO & EVP Returned to the company −3,394 $45.65 $155K 246,860
2023-03-01 Kassberg Thomas Richard CBO & EVP Grant or award · Stock Option (Right to Buy) +39,400 39,400
2023-03-01 Huizenga Theodore Alan SVP, Chief Accounting Officer Grant or award +7,590 23,148
2023-03-01 Huizenga Theodore Alan SVP, Chief Accounting Officer Sale −100 $45.65 $5K 23,048
2023-03-01 Huizenga Theodore Alan SVP, Chief Accounting Officer Returned to the company −1,333 $45.65 $61K 21,715
2023-03-01 Huizenga Theodore Alan SVP, Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +10,120 10,120
2023-03-01 Huang Dennis Karl See Remarks Grant or award +2,663 53,703

Page 13 of 21 · 410 trades